Cargando…

Anti-CD4-gp120 complex antibodies in long-term non-progressors HIV-1 positive patients: a role in slowing disease progression?

Detalles Bibliográficos
Autores principales:	Burastero, Samuele, Casoli, Claudio, Paolucci, Chiara, Breda, Paola, Alberti, Chiara, Pastori, Claudia, Lopalco, Lucia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716856/ http://dx.doi.org/10.1186/1742-4690-3-S1-P36

Ejemplares similares

Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4
por: Burastero, Samuele E., et al.
Publicado: (2011)

Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects
por: Canducci, Filippo, et al.
Publicado: (2009)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
por: Visciano, Maria Luisa, et al.
Publicado: (2008)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection
por: Burastero, Samuele E, et al.
Publicado: (2009)

Eliciting neutralizing antibodies with gp120 outer domain
por: Qin, Y, et al.
Publicado: (2012)

Role of anti-CD4-binding site antibodies in modulating gp120-specific CD4 T cell and antibody responses
por: Visciano, ML, et al.
Publicado: (2006)

Structural Basis for Species Selectivity in the HIV-1 gp120-CD4 Interaction: Restoring Affinity to gp120 in Murine CD4 Mimetic Peptides
por: Kassler, Kristin, et al.
Publicado: (2011)

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors
por: Frías, Aida, et al.
Publicado: (2023)

Human and chicken antibodies to CCR5-ECL1 block mucosal and systemic HIV infection
por: Lopalco, Lucia, et al.
Publicado: (2006)

Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity
por: Diskin, Ron, et al.
Publicado: (2010)

Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding
Publicado: (1990)

What Have Slow Progressors Taught Us About T1D—Mind the Gap!
por: Gillespie, Kathleen M., et al.
Publicado: (2019)

Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes
por: Boldison, Joanne, et al.
Publicado: (2021)

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status
por: Lucar, Olivier, et al.
Publicado: (2017)

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site
por: Dai, K, et al.
Publicado: (2012)

Slow Turnover of HIV-1 Receptors on Quiescent CD4(+) T Cells Causes Prolonged Surface Retention of gp120 Immune Complexes In Vivo
por: Suzuki, Yasuhiro, et al.
Publicado: (2014)

The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection
por: Venuti, Assunta, et al.
Publicado: (2017)

Allosteric induction of the CD4-bound conformation of HIV-1 Gp120
por: Roitburd-Berman, Anna, et al.
Publicado: (2013)

Closing the inequality gaps in reproductive, maternal, newborn and child health coverage: slow and fast progressors
por: Amouzou, Agbessi, et al.
Publicado: (2020)

Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
por: Mata-Fink, J, et al.
Publicado: (2012)

Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals
por: Carrillo, Jorge, et al.
Publicado: (2015)

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
por: Rusert, Peter, et al.
Publicado: (2011)

Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues
por: Gray, Lachlan, et al.
Publicado: (2011)

The first structure of HIV-1 gp120 with CD4 and CCR5 receptors
por: Guan, Yongjun
Publicado: (2019)

Study on molecular mechanisms of CD4 dependency and independency of HIV-1 gp120
por: Liu, Meng-Ting, et al.
Publicado: (2023)

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α(4)β(7)
por: Lertjuthaporn, Sakaorat, et al.
Publicado: (2018)

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors
por: El-Far, Mohamed, et al.
Publicado: (2016)

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
por: Ruprecht, Claudia R., et al.
Publicado: (2011)

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies
por: Czernekova, Lydie, et al.
Publicado: (2014)

Component-Resolved Diagnosis Based on a Recombinant Variant of Mus m 1 Lipocalin Allergen
por: Ferrari, Elena, et al.
Publicado: (2023)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
por: Strokappe, Nika M., et al.
Publicado: (2019)

HLA-C increases HIV-1 infectivity and is associated with gp120
por: Matucci, Andrea, et al.
Publicado: (2008)

Physiological Corticosterone Attenuates gp120-Mediated Microglial Activation and Is Associated with Reduced Anxiety-Like Behavior in gp120-Expressing Mice
por: Moss, Emaya M., et al.
Publicado: (2023)

Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors
por: Hayashida, Tsunefusa, et al.
Publicado: (2017)

Hyperglycosylated gp120 mutants elicit improved CD4-binding site directed antibodies in a heterologous prime:boost regimen
por: Ahmed, FK, et al.
Publicado: (2012)

Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120
por: Zhou, T, et al.
Publicado: (2012)

Internalization and Axonal Transport of the HIV Glycoprotein gp120
por: Berth, Sarah, et al.
Publicado: (2015)

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41
por: Zhang, Mei-Yun, et al.
Publicado: (2012)

CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ Phenotype
por: Trushin, Sergey A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_a9347atlqr8m9fi5htnmimf9br